The Role of Post-Translational Modifications of Metabolite-Related Proteins in Neuroblastoma: Mechanisms and Perspectives

Neuroblastoma (NB) is one of the most common extracranial solid tumours in children, and significant therapeutic challenges remain for high-risk patients and those with recurrent or refractory disease. In recent years, the link between tumour metabolic reprogramming and epigenetic regulation has become an increasingly important factor in explaining the heterogeneity, invasiveness, metastasis, immune evasion, and treatment resistance observed in NB. Post-translational modifications (PTMs) not only determine protein stability, subcellular localisation, and signal transduction but also respond directly to changes in metabolite concentrations, translating the metabolic state of metabolites into alterations in chromatin and membrane signalling. This review focuses on post-translational modifications intimately associated with metabolic processes (lactylation, acetylation, glycosylation, and palmitoylation, among others), and their potential mechanisms of action, current evidence, and translational prospects in NB are examined. Research indicates that pathways such as MYCN, LDHA, and ACSS2 collectively shape the metabolic profile of NB; amongst these, lactic acid production and acetylation are already supported by relatively direct mechanistic evidence in NB, whilst glycosylation is closely associated with GD2-targeted therapy, risk stratification, and tumour immunity. Direct research into palmitoylation in NB remains relatively limited; however, its regulation of oncogenic pathways, membrane receptors, and lipid raft signalling suggests that it may be involved in NB progression. In this review, the literature on metabolism-related PTM dysregulation in neuroblastoma is systematically synthesised, highlighting its key regulatory role. Overall, metabolite-related PTMs offer new avenues for research into the molecular subtyping, prognostic assessment, and combination therapy of neuroblastoma.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-17
DOI
https://doi.org/10.3390/cimb48111241
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Role of Post-Translational Modifications of Metabolite-Related Proteins in Neuroblastoma: Mechanisms and Perspectives

刘爱国, Dedong Zhang, Jiasi Zhang, Jiale Liu et al.
5 links
Current Issues in Molecular Biology
Neuroblastoma Research and Treatments
article

The Role of Post-Translational Modifications of Metabolite-Related Proteins in Neuroblastoma: Mechanisms and Perspectives

刘爱国, Dedong Zhang, Jiasi Zhang, Jiale Liu, Liman Lin, Yongbing Zhu, Kai Huang, Huifang Deng
article en

Abstract

Neuroblastoma (NB) is one of the most common extracranial solid tumours in children, and significant therapeutic challenges remain for high-risk patients and those with recurrent or refractory disease. In recent years, the link between tumour metabolic reprogramming and epigenetic regulation has become an increasingly important factor in explaining the heterogeneity, invasiveness, metastasis, immune evasion, and treatment resistance observed in NB. Post-translational modifications (PTMs) not only determine protein stability, subcellular localisation, and signal transduction but also respond directly to changes in metabolite concentrations, translating the metabolic state of metabolites into alterations in chromatin and membrane signalling. This review focuses on post-translational modifications intimately associated with metabolic processes (lactylation, acetylation, glycosylation, and palmitoylation, among others), and their potential mechanisms of action, current evidence, and translational prospects in NB are examined. Research indicates that pathways such as MYCN, LDHA, and ACSS2 collectively shape the metabolic profile of NB; amongst these, lactic acid production and acetylation are already supported by relatively direct mechanistic evidence in NB, whilst glycosylation is closely associated with GD2-targeted therapy, risk stratification, and tumour immunity. Direct research into palmitoylation in NB remains relatively limited; however, its regulation of oncogenic pathways, membrane receptors, and lipid raft signalling suggests that it may be involved in NB progression. In this review, the literature on metabolism-related PTM dysregulation in neuroblastoma is systematically synthesised, highlighting its key regulatory role. Overall, metabolite-related PTMs offer new avenues for research into the molecular subtyping, prognostic assessment, and combination therapy of neuroblastoma.

Current Issues in Molecular BiologyVol. 48(11)
Wuhan Union Hospital (CN), Tongji Hospital (CN), Union Hospital (CN), Huazhong University of Science and Technology (CN)
Good health and well-being
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon